Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. - Wikidata - wikimedia - TriplyDB

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

http://www.wikidata.org/entity/Q37505684

about

Stem cell transplantation therapy in Parkinson's disease Alternative Donor Transplantation for Acute Myeloid Leukemia Umbilical cord blood transplantation for the treatment of hematologic malignancies Advances in umbilical cord blood manipulation-from niche to bedside Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation.Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Umbilical cord blood transplantation: the first 25 years and beyond.Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells).A soluble granulocyte colony stimulating factor decoy receptor as a novel tool to increase hematopoietic cell homing and reconstitution in mice.Factors predicting single-unit predominance after double umbilical cord blood transplantation.Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns.Future of cord blood for oncology uses.Going straight to the point: intra-BM injection of hematopoietic progenitors.Double umbilical cord blood transplant: more than a cell dose?Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea.Cord blood stem cells for hematopoietic transplantation.An overview of the progress on double umbilical cord blood transplantation.Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics.Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood.Cord Blood Transplantation: Can We Make it Better?Advances in umbilical cord blood cell therapy: the present and the future.Phase II study of intrabone single unit cord blood transplantation for hematological malignancies A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database.Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium.Double cord blood transplantation: co-operation or competition?Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice.Indiscernible Benefit of Double-Unit Umbilical Cord Blood Transplantation in Children: A Single-Center Experience From Hong Kong.Overcoming the barriers to umbilical cord blood transplantation.A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning.Comparative in vitro analysis of different hematopoietic cell populations from human cord blood: in search of the best option for clinically oriented ex vivo cell expansion.Going home for the holidays? Take a shortcut!Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.Functional Integrity and Gene Expression Profiles of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro.Evaluation of hematopoietic stem cell expansion in the presence of garcinol

P2860

Q26778682-A3DDC278-661E-474F-AF54-FD4807EA0A55 Q26799456-466F2316-031E-4DF6-92AF-C64318FAA763 Q26820829-71BBF1D0-92E2-4B74-9357-896E58C81F85 Q26824305-A88A8D04-A2BD-47C3-913E-8721F4D02F53 Q30366297-3B28F32B-0F7F-437D-BD6F-E350BBB90891 Q33821459-2475E1A1-F8A4-451F-9B49-5094086752A8 Q34232835-C748F993-CC27-4549-AA21-CEDCD423F33E Q34344669-5D2A8484-C842-43E5-8E15-F525F683F108 Q34440672-55F81CF9-D559-4CC0-AE1A-F3A7EC0272B4 Q35746929-2A058B94-EB4E-4055-BD20-463696C2F0B5 Q36192813-F7966C91-19D8-4F07-BFF8-B90CF276DE2D Q36288646-B53C7E71-A7E4-4381-AD80-4D1DE5140473 Q36648047-35A9B2B5-6DB5-4113-A319-544C91F8C77F Q36664471-8520FA19-ADE1-4040-B44B-63B0D3E6FB69 Q37443125-50ABF903-4FE0-4EC2-9AEA-CBEA11D1D5AE Q37607977-918163DD-5946-4980-92DF-AAC69F3ACEA2 Q37715706-9191ED88-FEBB-45FA-B221-9DE4B54968E7 Q37724186-B55E8BAA-79DF-4F80-AEFD-22DC25630A37 Q37725142-A475056A-5A0C-4009-BBD0-C788842B674E Q37784455-62E101D8-7AA7-449A-86B1-6E910C1B3D75 Q37872506-A649D060-3118-4A76-A606-DF54EB117D85 Q37954790-7316AD79-72F0-4A82-832A-EDC2954A2719 Q38014665-EBCD703C-CD35-4738-8D34-316F5D4CF0FB Q38087853-2BD148B1-A4B3-4D97-A2B8-FF38CE7F27C5 Q38097003-3144636D-2487-494E-B0FA-B08A62DEBB30 Q38142167-113959A9-367D-41F0-89E6-DB2EEFFEC757 Q38734758-FF5621EA-1D68-446B-9B66-73AD24990A21 Q38743140-981B5E16-DA36-479F-A03C-3666ACC40BB2 Q39031937-2F157FFD-6C19-4558-9F5F-88EDFC1A4215 Q39042577-FB428725-FA18-4931-9AC6-61818A6A671D Q39805764-1B7EA2E8-BBA5-4C83-8937-091BB68CBBA0 Q40025549-9B264646-0F6C-4654-BACA-A2F88CF5F5C8 Q40472138-6ADD3D36-9367-4080-9197-EF6A82FB8E0D Q42974699-168EB1F5-8391-4156-88A4-C597D9F00EA8 Q47228036-E27EC66D-82E5-47FA-BB56-773D7050548D Q47326106-1D747B41-F0AA-41D8-A2BE-D2DECA35AC42 Q48324190-EBEDC6A7-56FD-4C6D-A525-65A2A33093B8 Q50531641-2D09AFA1-A23C-49AF-ACE8-642D64EB40A4 Q53281888-1EBEF226-3D00-420B-A090-36A887FB8C93 Q58130720-A6EDD65A-DEB8-4039-9637-D6101523FFF2

P2860

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

http://www.wikidata.org/entity/Q37505684

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intra-BM injection to enhance ...... o partially HLA-matched units.

@en

Intra-BM injection to enhance ...... o partially HLA-matched units.

@nl

type

label

Intra-BM injection to enhance ...... o partially HLA-matched units.

@en

Intra-BM injection to enhance ...... o partially HLA-matched units.

@nl

prefLabel

Intra-BM injection to enhance ...... o partially HLA-matched units.

@en

Intra-BM injection to enhance ...... o partially HLA-matched units.

@nl

P1433

Q37505684-7A2F061C-FABA-475E-94CC-8A7288BEAB2F

P1476

Q37505684-B54D173D-6F9C-4ED9-809E-60473EE2D23C

P2093

Q37505684-15621BA3-F42C-48D1-80FD-AD63BF8D104A

Q37505684-3BC0C3FD-2D6F-4086-A7FA-7F355A2F2C6A

Q37505684-62AFBC35-64A4-4E90-B68B-E1CD3BCBAE5B

Q37505684-8FE0ABDD-BB82-4918-A0D9-8B8FE33C5EC8

Q37505684-92E45D04-A468-4C53-A25F-EDE61C2AD59C

Q37505684-96C4F138-F559-4BF7-B077-79E332C9CA99

Q37505684-AFC647F4-47B8-416A-9BB2-04D2B9BA1081

Q37505684-C5259399-6787-4A3B-825D-13F8C2035DCA

P2860

Q37505684-078100E2-46E1-4628-B2D8-618820413B9B

Q37505684-13D521DF-5364-4D60-B1ED-B0CD99524DA4

Q37505684-15BE7DEE-47A2-4707-93A1-D2ACE59550C5

Q37505684-1B1DEE8B-F528-469F-BBDD-1FBBBDECA4EF

Q37505684-3B114348-82E6-4850-98F2-EE7BB2488873

Q37505684-6AF84C32-2E8C-482F-BE36-C0A9ECF197CF

Q37505684-6AF9D627-F928-4971-9301-C22651BF8291

Q37505684-7C0AC7F1-1550-484E-A7AA-F2CA81B522C9

Q37505684-8EB7F7C6-D439-4C0B-8BB0-49D4AA4715A2

Q37505684-92EF84BE-CB53-4ED2-B3C7-BEF14DC49EF2

P2888

Q37505684-D1A74DCC-6D2B-4D31-BC5D-50731E82A74E

P304

Q37505684-03AC98AC-D616-4E21-A4CB-80F55BBE0FF4

P31

Q37505684-2C6A7594-8D4A-4346-9FC2-7D0AF638F0EE

P356

Q37505684-DF761AB8-C3AE-4D27-9601-1E7054987AF1

P407

Q37505684-94590422-7956-4EEF-9DBD-058B33F3FEEC

P433

Q37505684-1B061C27-3E5F-4D6B-ABED-BFC4023C6BF0

P478

Q37505684-2860DED2-9C83-415A-AC61-0F6EF6474EC3

P50

Q37505684-C3584FA0-BDDB-40B8-8772-4C003B6736DF

P577

Q37505684-32E133A9-46FB-4071-B8E7-DE6B0B2C44C4

P5875

Q37505684-BC98915C-FC29-4C3B-88C3-0A6117BC8065

P698

Q37505684-D50F38F6-4C74-45E8-82E3-5F0BB6F3E5DF

P932

Q37505684-8C0BA492-0E30-485C-9A29-8F845EA3C4AB

P356

P1433

Bone Marrow Transplantation

P1476

Intra-BM injection to enhance ...... wo partially HLA-matched units

@en

P2093

C G Brunstein

http://www.w3.org/2001/XMLSchema#string

D J Weisdorf

http://www.w3.org/2001/XMLSchema#string

D McKenna

http://www.w3.org/2001/XMLSchema#string

J E Wagner

http://www.w3.org/2001/XMLSchema#string

J N Barker

http://www.w3.org/2001/XMLSchema#string

P B McGlave

http://www.w3.org/2001/XMLSchema#string

S Y Chong

http://www.w3.org/2001/XMLSchema#string

T E Defor

http://www.w3.org/2001/XMLSchema#string

P2860

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

1994 Consensus Conference on Acute GVHD Grading

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

P2888

P304

935-940

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2008.417

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey S. Miller

P577

2009-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23782955

http://www.w3.org/2001/XMLSchema#string

P698

19139736

http://www.w3.org/2001/XMLSchema#string

P932

5157830

http://www.w3.org/2001/XMLSchema#string